{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:48:14Z","timestamp":1774072094049,"version":"3.50.1"},"reference-count":30,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2013,4,12]],"date-time":"2013-04-12T00:00:00Z","timestamp":1365724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabet. Med."],"published-print":{"date-parts":[[2013,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>To examine the associations of the liver enzymes alanine aminotransferase (ALT), aspartate aminotransferase(AST), and gamma\u2010glutamyl transferase (GGT) with diabetes risk and to determine whether associations differ by race and\/or gender. We hypothesized that all liver enzymes would be associated with diabetes risk and that associations would differ by race and gender.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Prospective cohort of 7495 white and 1842 black participants without diabetes in the Atherosclerosis Risk in Communities Study. Poisson and Cox models adjusted for demographic, socio\u2010behavioural, and metabolic and health\u2010related factors were used.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>During a median of 12\u00a0years of follow\u2010up, 2182 incident cases of diabetes occurred. Higher liver enzyme levels were independently associated with diabetes risk: adjusted hazard ratios (95% confidence intervals) were 1.68 (1.49\u20131.89), 1.16 (1.02\u20131.31) and 1.95 (1.70\u20132.24) comparing the highest with the lowest quartiles of ALT, AST, and GGT, respectively. Gamma\u2010Glutamyl transferase was most strongly related to diabetes risk, even at levels considered within the normal range (\u2264\u00a060 U\/l) in clinical practice. Adjusted incidence rates by quartiles of liver enzymes were similar by gender but higher in black versus white participants. Nonetheless, relative associations of ALT, AST, and GGT with diabetes were similar by race (<jats:italic>P<\/jats:italic> for interactions\u00a0&gt;\u00a00.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Compared with ALT and AST, GGT was more strongly associated with diabetes risk. Our findings suggest that abnormalities in liver enzymes precede the diagnosis of diabetes by many years and that individuals with elevated liver enzymes, even within the normal range as defined in clinical practice, are at high risk for diabetes.<\/jats:p><\/jats:sec>","DOI":"10.1111\/dme.12187","type":"journal-article","created":{"date-parts":[[2013,3,20]],"date-time":"2013-03-20T05:02:38Z","timestamp":1363755758000},"page":"926-933","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study"],"prefix":"10.1111","volume":"30","author":[{"given":"A. L. C.","family":"Schneider","sequence":"first","affiliation":[{"name":"Department of Epidemiology Bloomberg School of Public Health  Minnesota USA"},{"name":"Welch Center for Prevention, Epidemiology, and Clinical Research Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lazo","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Bloomberg School of Public Health  Minnesota USA"},{"name":"Welch Center for Prevention, Epidemiology, and Clinical Research Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. E.","family":"Ndumele","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Bloomberg School of Public Health  Minnesota USA"},{"name":"Welch Center for Prevention, Epidemiology, and Clinical Research Minnesota USA"},{"name":"Department of Medicine The Johns Hopkins University School of Medicine Baltimore Maryland USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. S.","family":"Pankow","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Community Health University of Minnesota Minneapolis Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Coresh","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Bloomberg School of Public Health  Minnesota USA"},{"name":"Welch Center for Prevention, Epidemiology, and Clinical Research Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Clark","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Bloomberg School of Public Health  Minnesota USA"},{"name":"Welch Center for Prevention, Epidemiology, and Clinical Research Minnesota USA"},{"name":"Department of Medicine The Johns Hopkins University School of Medicine Baltimore Maryland USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Selvin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Bloomberg School of Public Health  Minnesota USA"},{"name":"Welch Center for Prevention, Epidemiology, and Clinical Research Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,4,12]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07486.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1870"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20466"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d6891"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1296"},{"key":"e_1_2_6_7_1","volume-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2010"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2004.04.008"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.10.2623"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1373\/49.8.1358"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a115184"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24376"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws156"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1262-3636(07)70229-X"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-2159"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0505"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2005.01572.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2007.10.015"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.11.2855"},{"key":"e_1_2_6_20_1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00125-003-1036-5","article-title":"Gamma\u2010glutamyltransferase and diabetes \u2013 a 4\u00a0year follow\u2010up study","volume":"46","author":"Lee DH","year":"2003","journal-title":"Diabetologia"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2007.218"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2008.02410.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2.5.705"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04639.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22726"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/10715760410001694026"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-5-200803040-00005"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50291"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(00)00623-7"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwr326"},{"issue":"1","key":"e_1_2_6_31_1","first-page":"S11","article-title":"Standards of medical care in diabetes \u2013 2012","volume":"35","author":"American Diabetes Association","year":"2012","journal-title":"Diabetes Care"}],"container-title":["Diabetic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdme.12187","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dme.12187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T04:45:50Z","timestamp":1696221950000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dme.12187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,12]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["10.1111\/dme.12187"],"URL":"https:\/\/doi.org\/10.1111\/dme.12187","archive":["Portico"],"relation":{},"ISSN":["0742-3071","1464-5491"],"issn-type":[{"value":"0742-3071","type":"print"},{"value":"1464-5491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,12]]},"assertion":[{"value":"2013-03-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-04-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}